Table 2.

Correlations between sex and age of participants on the life time prevalence.

Age groups (year)	Male (per 1000 persons)	Female (per 1000 persons)	Total (per 1000 persons)
0–4	13.0	24.1	18.8
5–9	17.3	3.3	10.8
10–14	23.4	14.6	19.2
15–19	45.7	18.7	32.7
20–29	20.5	12.9	16.6
30–39	11.5	10.7	11.1
40–49	13.0	22.5	17.8
50–59	23.0	16.9	19.8
60–69	13.7	16.1	14.9
70–79	15.4	18.9	17.0
≥ 80	21.5	35.7	27.1
Life-time prevalence	17.8 (16.0–19.5 CI 95%)	15.5 (13.8–17.2 CI 95%)	16.6 (15.4–17.8 CI 95%)